- Products & Solutions
- FDA IVD
- About Us
- News & Events
- Contact
- Additional Sites
Category: BÜHLMANN Quantum Blue® IFX
Apologies, but no results were found for the requested archive.
- 100 BÜHLMANN Calprotectin Publications
- A New Rapid Quantitative Test for Fecal Calprotectin Predicts Endoscopic Activity in Ulcerative Colitis
- A New Rapid Test for Fecal Calprotectin Predicts Endoscopic Remission and Postoperative Recurrence in Crohn’s Disease.
- A Novel Turbidimetric Immunoassay for Fecal Calprotectin Optimized for Routine Chemistry Analyzers
- A Pilot Study Using Point of Care Testing for IFX and Faecal Calprotectin in IBD Patients
- Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease
- Acute Neurological Worsening After Rituximab Treatment in Patients with Anti-MAG Neuropathy
- Agreement Between Home-based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity
- AMLI 2024 Recap for BUHLMANN Diagnostics Corp
- An Autopsy Case of Amyotrophic Lateral Sclerosis with Waldenström Macroglobulinemia and Anti-MAG Gammopathy.
- Analytical and Diagnostic Performance of Two Automated Fecal Calprotectin Immunoassays for Detection of Inflammatory Bowel Disease
- Analytical Evaluation of a Fully Automated Immunoassay for Faecal Calprotectin in a Paediatric Setting
- Anaphylaxis to Galacto-Oligosaccharides–An Evaluation in an Atopic Population in Singapore
- Announcing Enhancement to Quantum Blue® fCAL (Calprotectin) High Range Assay
- Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited
- Anti-ganglioside Antibodies were not Detected in Human Subjects Infected with or Vaccinated Against 2009 Pandemic Influenza A (H1N1) Virus
- Anti-Myelin Associated Glycoprotein Antibodies Recognize HNK-1 Epitope on CNS
- Anti-Myelin-Associated Glycoprotein Neuropathy
- Are We Exposing Patients with a Mildly Elevated Faecal Calprotectin to Unnecessary Investigations?
- Assessment of Sensitization to Grape and Wine Allergens as Possible Causes of Adverse Reactions to Wine: A Pilot Study
- Automate fecal Calprotectin and Pancreatic Elastase assay testing, with BÜHLMANN fCAL® turbo & fPELA® turbo US IVD application
- Basophil Activation Test Discriminates Between Allergy and Tolerance in Peanut-Sensitized Children.
- Basophil Activation Test Identifies the Patients with Chronic Spontaneous Urticaria Suffering the Most Active Disease
- Basophil Activation Testing – Standardized
- Basophils Are Still Alive
- Benefit of the Basophil Activation Test in Deciding When to Reintroduce Cow’s Milk in Allergic Children
- Biomarkers as predictors of flares in inflammatory bowel disease
- Bringing Calprotectin Testing In-house on the Abbott Architect C8000
- Brutontyrosine Kinase Inhibitor Ibrutinib(PCI-32765) has Significant Activity in Patients with Relapsed/Refractory B-cell Malignancies
- Buhlmann – Next Generation Food Allergy Drug Development Summit
- BUHLMANN announces new Microsite for Kinase Inhibition Assay
- BÜHLMANN anti Ganglioside antibodies Citations
- BÜHLMANN anti-MAG autoantibodies ELISA Citations
- BÜHLMANN anti-SGPG autoantibodies ELISA Citations
- BÜHLMANN CAST® Drug Allergens: New Products
- BUHLMANN Debriefing- EuroMedLab 2019
- BUHLMANN Diagnostic Corp – New Collaboration with Beckman Coulter
- BUHLMANN Diagnostic Corp – New Partner Channel Agreement with Roche Diagnostics
- BUHLMANN Diagnostics Corp Announces New Distribution Agreement with Meridian Biosciences, Inc.
- BUHLMANN Diagnostics Corp Recap from DDW 2024
- BUHLMANN Diagnostics Corp’s ADLM 2024 Recap
- BUHLMANN fCAL® turbo (calprotectin)
- BÜHLMANN fCAL® turbo Customer Testimonials
- BÜHLMANN fCAL® turbo Promotion
- BÜHLMANN fCAL® turbo Success Story- Freeman Hospital, Newcastle
- BUHLMANN Flow CAST Kinase Inhibition Assay and Utilization in Research
- BÜHLMANN GanglioCombi™ MAG ELISA Utilized in Guillain-Barré Syndrome (GBS) and Zika Virus Study
- BUHLMANN Highlights: GanglioCombi MAG ELISA
- BUHLMANN Highlights: Neuroimmune Biomarkers, Esoteric Testing, and Utilization in Research
- BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter for BÜHLMANN fCAL turbo and fPELA turbo Assays
- AACC
- AACC 2016
- AACC 2017
- ADLM
- Allergens
- Allergy Technical News
- AMLI
- AMLI 2016
- BUHLMANN Citations
- Anti-Ganglioside Antibody Citations
- Anti-MAG Autoantibodies Citations
- BÜHLMANN Anti-ganglioside Antibodies Assay Citations
- BÜHLMANN Anti-MAG Autoantibodies Assay Citations:
- BÜHLMANN CALEX® Cap Citations
- BÜHLMANN Calprotectin Assay Citations
- BÜHLMANN fCAL® ELISA Assay Citations
- BÜHLMANN fCAL® turbo Citations
- BÜHLMANN Flow CAST® Allergy Assay Citations
- BÜHLMANN Gangliocombi™ MAG ELISA Citations
- BÜHLMANN Kinase Inhibition Assays Citations
- BÜHLMANN Neuroimmunology Assay Citations
- BÜHLMANN Quantum Blue® Citations
- BÜHLMANN Quantum Blue® fCAL Citations
- BÜHLMANN Quantum Blue® fCAL extended Citations
- BÜHLMANN Quantum Blue® IFX Assay Citations
- Calprotectin Citations
- IBDoc® Citations
- BUHLMANN CORP
- Buhlmann Diagnostics Corp
- Buhlmann Diagnostics Events
- BÜHLMANN Flow CAST® News
- BÜHLMANN GanglioCombi ELISA Citations
- BÜHLMANN Gangliocombi™ MAG ELISA
- BUHLMANN Highlights
- BUHLMANN LabSense News
- BÜHLMANN Quantum Blue® TDM Assay Citations
- CALEX® Cap
- Calprotectin Technical Post
- CDDW 2016
- DDW
- DDW 2016
- DDW 2017
- eBooks
- Events
- Flow CAST®
- IBD Literature
- IBDoc®
- IBDoc® News
- Kinase Inhibition Assays
- Literature
- MGCC 2016
- News
- News
- Promotions
- Special Pricing
- Success Stories
- Technical News
- Technical Posts
- Technical Videos
- Uncategorized
